GSK’s challenging year | FT Business

► Subscribe to the Financial Times on YouTube: Sir Andrew Witty, chief executive of GlaxoSmithKline, talks to the FT’s pharmaceuticals correspondent Andrew Ward about a challenging past year for the drugmaker and his strategy for returning it to growth. ► FT Business: ► UK Business & Politics: ► SABMiller Looks to craft beer for growth: For more video content from the Financial Times, visit